Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Rule 8.3 - Flying Brands

3 Oct 2008 09:14

FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION \* TName of person dealing (Note 1) River and Mercantile Asset Management---------------------------------------------------------------------------------------------------------Company dealt in Flying Brands UTS---------------------------------------------------------------------------------------------------------Class of relevant security to which the Securities of the offeree company dealings being disclosed relate (Note 2)---------------------------------------------------------------------------------------------------------Date of dealing 02/10/08---------------------------------------------------------------------------------------------------------\* T 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) \* T Long Short-------------------------------------------------------------------------------------------------------- Number (%) Number (%)--------------------------------------------------------------------------------------------------------(1) Relevant securities 2,177,558 8.59%--------------------------------------------------------------------------------------------------------(2) Derivatives (other than options)--------------------------------------------------------------------------------------------------------(3) Options and agreements to purchase/sell--------------------------------------------------------------------------------------------------------Total--------------------------------------------------------------------------------------------------------\* T (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) \* T Class of relevant security: Long Short-------------------------------------------------------------------------------------------------------- Number (%) Number (%)--------------------------------------------------------------------------------------------------------(1) Relevant securities--------------------------------------------------------------------------------------------------------(2) Derivatives (other than options)--------------------------------------------------------------------------------------------------------(3) Options and agreements to purchase/sell--------------------------------------------------------------------------------------------------------Total--------------------------------------------------------------------------------------------------------\* T (c) Rights to subscribe (Note 3) \* TClass of relevant security: Details---------------------------------------------------------------------------------------------------------1 Ord 0.005P---------------------------------------------------------------------------------------------------------\* T 3. DEALINGS (Note 4) (a) Purchases and sales \* TPurchase/sale Number of securities Price per unit (Note 5)---------------------------------------------------------------------------------------------------------Purchase 105,000£0.45---------------------------------------------------------------------------------------------------------\* T (b) Derivatives transactions (other than options) \* TProduct name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)e.g. CFD--------------------------------------------------------------------------------------------------------\* T (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying \* TProduct name, Writing, Number of Exercise Type, e.g. Expiry Option moneye.g. call option selling, securities to price American, date paid/received purchasing, which the option European per unit (Note varying etc. relates (Note 7) etc. 5)-------------------------------------------------------------------------------------------------------\* T (ii) Exercising \* TProduct name, e.g. call option Number of securities Exercise price per unit (Note 5)---------------------------------------------------------------------------------------------------------\* T (d) Other dealings (including new securities) (Note 4) \* TNature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)---------------------------------------------------------------------------------------------------------\* T 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives \* TFull details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.---------------------------------------------------------------------------------------------------------\* T Is a Supplemental Form 8 attached? (Note 9) YES/NO \* TDate of disclosure 03/10/08---------------------------------------------------------------------------------------------------------Contact name Michael Anglim---------------------------------------------------------------------------------------------------------Telephone number 020 7601 6247---------------------------------------------------------------------------------------------------------If a connected EFM, name of offeree/offeror with which connected---------------------------------------------------------------------------------------------------------If a connected EFM, state nature of connection (Note 10)---------------------------------------------------------------------------------------------------------\* T Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk Copyright Business Wire 2008
Date   Source Headline
20th Nov 20209:00 amRNSPrice Monitoring Extension
17th Nov 20201:26 pmRNSDirector/PDMR Shareholding
13th Nov 202011:05 amRNSSecond Price Monitoring Extn
13th Nov 202011:00 amRNSPrice Monitoring Extension
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20202:01 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSCorrection: Director Dealing and CLN Conversion
11th Nov 20207:00 amRNSDirector Dealing and Conversion of Loan Notes
10th Nov 20204:35 pmRNSPrice Monitoring Extension
10th Nov 20202:06 pmRNSSecond Price Monitoring Extn
10th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 202011:06 amRNSSecond Price Monitoring Extn
10th Nov 202011:01 amRNSPrice Monitoring Extension
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 202011:05 amRNSSecond Price Monitoring Extn
9th Nov 202011:00 amRNSPrice Monitoring Extension
9th Nov 20209:05 amRNSSecond Price Monitoring Extn
9th Nov 20209:00 amRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSIB and the Mayo Clinic enter into an Agreement
6th Nov 20204:35 pmRNSPrice Monitoring Extension
6th Nov 20202:05 pmRNSSecond Price Monitoring Extn
6th Nov 20202:00 pmRNSPrice Monitoring Extension
6th Nov 202011:05 amRNSSecond Price Monitoring Extn
6th Nov 202011:00 amRNSPrice Monitoring Extension
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Nov 20209:00 amRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSMontgomery Cancer Center Purchases IB's Software
4th Nov 20207:00 amRNSLSN Software Receives FDA Clearance
30th Oct 202011:05 amRNSSecond Price Monitoring Extn
30th Oct 202011:00 amRNSPrice Monitoring Extension
30th Oct 20207:00 amRNS"Gad Free" Imaging moves to Validation Testing
15th Oct 20207:00 amRNSIB Stroke
8th Oct 20203:41 pmRNSStoneChecker Update
24th Sep 202010:43 amRNSThe Benefits and Significance of IB Neuro
16th Sep 20207:00 amRNSKeck Medical Centre of USC Purchases IB's Software
10th Sep 20207:00 amRNSIB Trax™
4th Sep 20209:03 amRNS“Gad Free” Imaging - One Step Closer
7th Aug 20207:00 amRNSHalf-year Report
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 202011:05 amRNSSecond Price Monitoring Extn
5th Aug 202011:00 amRNSPrice Monitoring Extension
5th Aug 20209:53 amRNSStonechecker Update
27th Jul 20207:00 amRNSUpdate - IB Stroke
10th Jul 20207:00 amRNSNew Development Aims to Detect Tumor Infiltration
19th Jun 20207:00 amRNSIB, the Recognised National Standard in MRI DSC
15th Jun 202011:52 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.